|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dr Jeroen Aerssens, Head Translational Genomics & Genetics, European Discovery Capabilities, Tibotec BVBA - Johnson & Johnson
|
|
|
|
Dr Roman Artymyshyn, Principal Scientist, Target Discovery and Assessment, Lundbeck Research
|
|
|
|
Mirco Castoldi, Postdoctoral Fellow, Hentze Group, EMBL Heidelberg, Germany
|
|
|
|
Dr. Raffaele Di Francia, Lab of Molecular Hematology, Institute of Tumors G. Pascale
|
|
|
|
Dr. Benaissa El-Moualij, Center of Immunology, Institute of Pathology, University of Liege
|
|
|
|
Dr Olivier Grenet, Group Head Genome Biology, Investigative Toxicology, Translational Sciences, Novartis Pharma
|
|
|
|
Susanne Heinsohn, University Hospital Hamburg-Eppendorf, Clinic for Hematology and Oncology, Germany
|
|
|
|
Jean-Luc Henrioul, Commercial and Business Development Director, BioXpr
|
|
|
|
Stig Ove Hjelmevoll, Scientist, Department of Microbiology and Infection Control, University Hospital of North Norway
|
|
|
|
Sami Hokkanen, Senior Biostatician, Research & Translational Statistics, Biostatistics & Support Functions, R&D, Orion Pharma
|
|
|
|
Dr. Nana Jacobsen, Senior Scientist, Exiqon
|
|
|
|
Dr. Ian Kavanagh, Research and Develoment Manager, Thermo Scientific Genomics
|
|
|
|
Dr. Hansjoerg Keller, Senior Research Investigator, Novartis
|
|
|
|
Dr Gustavo H. Kijak, Chief of Section Host Genetics, Military HIV Program, Henry M Jackson Foundation
|
|
|
|
Dr. Jan Kristek, Director and Head of Immunological Department, Karlovarske Imunologicke Centrum
|
|
|
|
Paul E. Kroeger, Senior Group Leader GPRD, Neuroscience & Pain Discovery, Abbott Laboratories
|
|
|
|
Prof. Michael Kubista, Head Laboratoř genové exprese, Biotechnologický ústav AV ČR
|
|
|
|
Dr Viktor Lakics, Senior Research Scientist - Neurodegeneration DHT, Eli Lilly
|
|
|
|
Ralf Mauritz, Director, R&D, Roche Diagnostics GmbH
|
|
|
|
Patricia McLoughlin, Head of Genomics, F. Hoffmann-La Roche Ltd
|
|
|
|
Afif Abdel Nour, Research Scientist, Molecular Biotechnology, Institut Polytechnique LaSalle Beauvais
|
|
|
|
Dr Veronika Okršlar, Biopharmaceuticals, Cell and Molecular Biology, Lek Pharmaceuticals d.d.a. Sandoz Company
|
|
|
|
Prof. Claudio Orlando, Professor, Clinical Biochemistry Unit, Department of Clinical Physiopathology, University of Florence
|
|
|
|
Dr Natasha Paul, Senior Staff Scientist, TriLink Biotechnologies
|
|
|
|
Senior Representative, Qiagen
|
|
|
|
Dr. Jan M. Ruijter, Department of Anatomy and Embryology, Academic Medical Centre, Amsterdam
|
|
|
|
Dr Chaminda Salgado, Head of PCR Services, Pharmaceutical Analysis, NDA Analytics
|
|
|
|
Dr. Mathias Schmidt, Associate Principal, Strategic Planning and Business Support, Nycomed GmbH
|
|
|
|
Dr Andrej-Nikolai Speiss, Department of Andrology, University Hospital Hamburg-Eppendorf
|
|
|
|
Dr. Rolf Studer, Senior Lab Head, Actelion
|
|
|
|
Dr Marco Tomasetti, Department of Molecular Pathology and Innovative Therapies, Polytechnic University of Marche, Italy
|
|
|
|
Dr. Emiliano Toso Head of the Molecular Biology Laboratory RBM Merk Serono
|
|
|
|
Dr. Thorsten Traeger, Project Manager, R&D, Qiagen
|
|
|
|
Dr Ales Trichopad, Co Founder and CTO, Labonnet
|
|
|
|
Dr. Victor Turcanu, Lecturer in Paediatric Allergy, Division of Asthma, Allergy and Lung Biology, King's College London
|
|
|
|
Dr Dan Turner, Head of Sequencing Technology, Wellcome Trust Sanger Institute
|
|
|
|
Andreas Weinhausel, Senior Scientist, Molecular Diagnostics, Austrian Research Centers ARC
|
|
|
|
Dr Jo Woods, Senior Research Scientist, MedImmune
|
|
|
|
Dr. Neven Zoric, CEO, TATAA Biocenter
|
|
|
|
|
|
|
|
Speakers
